Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-10-05

Clinical Trial Update: Rosuvastatin for Preventing Deep Vein Thrombosis [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial evaluating rosuvastatin for the prevention of deep vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CRESTOR (Rosuvastatin)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Deep Vein Thrombosis, Venous | Phase 4 | Status: UNKNOWN